Over the past year there were no insider purchases at Dynavax Technologies Corp. One insider sold roughly $2.2 million instead.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Novack David F | COO | Sell | 114,000 | $15.64 | $1.8M | SEC |
| Dec 29, 2025 | Novack David F | COO | Sell | 30,000 | $15.49 | $465K | SEC |
| Aug 25, 2025 | Myers Scott Dunseth | Director | Buy | 3,800 | $10.82 | $41K | SEC |
| Aug 22, 2025 | Deep Track Capital, LP | 10% Owner | Sell | 970,143 | $10.59 | $10.3M | SEC |
| Aug 22, 2025 | Deep Track Capital, LP | 10% Owner | Sell | 1,094,994 | $11.03 | $12.1M | SEC |
| Mar 26, 2025 | Novack David F | COO | Sell | 10,000 | $14.00 | $140K | SEC |
| Mar 20, 2025 | Novack David F | COO | Sell | 14,020 | $13.58 | $190K | SEC |
| Mar 10, 2025 | Novack David F | COO | Sell | 32,764 | $14.39 | $471K | SEC |
| Jun 3, 2024 | CANO FRANCIS | Director | Sell | 3,615 | $11.93 | $43K | SEC |
| Mar 4, 2024 | Burgess Justin | Executive Officer | Sell | 13,425 | $12.78 | $172K | SEC |
| Mar 4, 2024 | Burgess Justin | Executive Officer | Sell | 7,101 | $12.78 | $91K | SEC |
| Jan 8, 2024 | Janssen Robert | Executive Officer | Sell | 1,500 | $15.00 | $22K | SEC |
| Jan 4, 2024 | Novack David F | COO | Sell | 9,000 | $14.45 | $130K | SEC |
| Dec 5, 2023 | Novack David F | COO | Sell | 20,000 | $13.56 | $271K | SEC |
| Nov 7, 2023 | Novack David F | COO | Sell | 20,000 | $15.00 | $300K | SEC |
In the last 12 months Dynavax Technologies Corp insiders made open-market purchases worth about $0 and sales worth about $2.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in DVAX was filed on 2026-01-20.
No congressional trades in DVAX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).